Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. oral administration
Show results for
Products
Services
Software

Companies

News
Articles
Downloads
Videos

Refine by
Date

  • Older

Oral Administration Articles & Analysis

30 news found

Why small molecule development?

Why small molecule development?

By leveraging the potential of small molecules, our clients can benefit from: Targeted Therapies - Small molecules can be designed to selectively modulate specific biological targets, allowing for precise intervention in disease processes. Oral Bioavailability - Many small molecules are suitable for oral administration, making them convenient and ...

ByProtheragen-ING


CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery   

CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery  

One of the key advantages of microneedles is its ability to bypass the oral route, which can often be associated with issues like poor bioavailability and gastrointestinal side effects. ...

ByCD Formulation


Will HIFU ultrasound machine treatment have side effects and sequelae

Will HIFU ultrasound machine treatment have side effects and sequelae

For HIFU ultrasonic beauty care, please do not go to high-temperature saunas, yoga and other high-temperature environments within one month after treatment, and do not expose to the sun, and do sun protection. 7. Avoid oral administration of pure collagen before and after HIFU treatment, especially after HIFU ultrasound treatment has already stimulated its own ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


HIFU Ultrasound machine treatment effect

HIFU Ultrasound machine treatment effect

Stimulate the epidermis through HIFU ultrasonic beauty equipment, combined with oral ACME-TE-A generating too, two-way combined anti-aging physiotherapy process, clinical verification, after the patient undergoes HIFU ultrasonic treatment, facial wrinkles, sagging, enlarged pores, and skin luster are uniform There are varying degrees of improvement. ...

ByBvlaser Bestview Medical and Beauty Equipment Co., Ltd


Bristol-Myers Squibb Awards First “Golden Tickets” for LabCentral to PanTher, Suono Bio

Bristol-Myers Squibb Awards First “Golden Tickets” for LabCentral to PanTher, Suono Bio

The company designed its novel delivery method to potentially eliminate the toxicity and debilitating side effects that chemo agents can produce when delivered systemically through traditional IV or oral administration. Its first potential indication is pancreatic cancer, a particularly lethal disease that affects more than 53,000 Americans annually, where ...

BySuono Bio


Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA System for Automated at Home Methadone Administration

Berkshire Biomedical Awarded NIH Research Grant to Support Continued Development of the COPA System for Automated at Home Methadone Administration

Valued at approximately $2.0 million over two years, the two-phase grant will support continued non-clinical development of the Company's Computerized Oral Prescription Administration System (COPA™) for at home methadone administration as part of Medication for Opioid User Disorder (MOUD) treatment. ...

ByBerkshire Biomedical


Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

Rani Therapeutics Unveils High-Capacity RaniPill Device for Oral Delivery of Biologics

Rani Therapeutics Holdings, Inc. recently announced the development of a high-capacity oral biologics device known as the RaniPill HC (High Capacity), capable of delivering up to a 500%-plus higher drug payload than Rani’s existing oral biologics capsule. ...

ByRani Therapeutics


Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

Lumos Pharma Announces a Clinical Collaboration with Massachusetts General Hospital (MGH) to Evaluate Oral LUM-201 in Nonalcoholic Fatty Liver Disease (NAFLD) in a Phase 2 Investigator-Initiated Trial

Based on these findings, LUM-201, an oral growth hormone secretagogue, could prove to be an efficacious therapeutic for those suffering from this chronic liver ...

ByLumos Pharma


Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma

Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma

The secondary objectives were to evaluate the safety, tolerability and any potential QT prolongation after a single oral administration of 150mg of the studied drug under fasted and fed conditions in healthy adult subjects. ...

ByAptorum Group Limited


Berkshire Biomedical, Developers of COPA, Recognizes National Prescription Drug Take Back Day

Berkshire Biomedical, Developers of COPA, Recognizes National Prescription Drug Take Back Day

Berkshire is developing drug dispensing technologies designed to deliver oral liquid drugs accurately and precisely. This is accomplished by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems, to provide accurate personalized medication delivery to only the authenticated Intended User. The Company’s lead ...

ByBerkshire Biomedical


Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

Neuropathix, Inc. Highlights Positive Preclinical Study Results on Lead Drug Candidate KLS-13019

Additional information from the study published in the British Journal of Pharmacology note, among other things, that “these studies demonstrate that like CBD, KLS-13019 can prevent the development of mechanical sensitivity following paclitaxel administration in mice, including following oral administration. Because KLS-13019, based on our ...

ByNeuropathix, Inc.


Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Creative Diagnostics Launches Staphylococcal Enterotoxin Antigens

Staphylococcal enterotoxins have been proposed to be named according to their emetic activity, and only superantigens that cause emesis after oral administration in primate models will be named SEs. The repertoire of S. aureus SEs/SEls includes 22 members, excluding molecular variants. ...

ByCreative Diagnostics


Berkshire Biomedical, Developers of COPA,  Featured as a 2022 Top Texas Tech Startup in StartupCity Magazine

Berkshire Biomedical, Developers of COPA, Featured as a 2022 Top Texas Tech Startup in StartupCity Magazine

The Company announced today that its lead product, the Computerized Oral Prescription Administration System (COPA™), has been honored as a 2022 Top Texas Tech Startup in the new edition of StartupCity Magazine. ...

ByBerkshire Biomedical


Berkshire Biomedical to Present at the LSI USA ’22 Emerging Medtech Summit

Berkshire Biomedical to Present at the LSI USA ’22 Emerging Medtech Summit

The presentation will highlight Berkshire’s Computerized Oral Prescription Administration System (COPA™), a novel oral liquid dispensing system specifically designed to deliver accurate and precise doses of controlled and non-controlled prescription medications to only a biometrically authenticated Intended User, with the goal of ...

ByBerkshire Biomedical


Altamira Therapeutics Completes Final Patient Enrollment in Phase 2 `TRAVERS` Clinical Trial of AM-125 for the Treatment of Acute Vertigo

Altamira Therapeutics Completes Final Patient Enrollment in Phase 2 `TRAVERS` Clinical Trial of AM-125 for the Treatment of Acute Vertigo

It increases cochlear, vestibular and cerebral blood flow and facilitates vestibular compensation and inhibits neuronal firing in the vestibular nuclei. Betahistine for oral administration is approved in about 115 countries (with the U.S. being a notable exception) for the treatment of vertigo and Meniere's disease. Despite its good safety profile, the clinical ...

ByAuris Medical AG


Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Berkshire Biomedical to Participate in the LSX 6th Annual Investment Showcase

Berkshire Biomedical Corporation (“Berkshire” or “the Company”), focused on developing drug delivery devices designed to accurately and precisely deliver oral liquid drugs only to the biometrically authenticated Intended User, provide remote monitoring and enhance patient wellness, announced today that John Timberlake, Chief Executive Officer of Berkshire ...

ByBerkshire Biomedical


Berkshire Biomedical Recognizes International Overdose Awareness Day

Berkshire Biomedical Recognizes International Overdose Awareness Day

Berkshire Biomedical, LLC (“Berkshire” or “the Company”), focused on developing drug delivery devices designed to precisely deliver oral liquid drugs only to the biometrically authenticated Intended User, provide remote monitoring and enhance patient wellness, announces today that it joins with the millions of advocates around the world in recognition of ...

ByBerkshire Biomedical


Oligomerix Presents Preclinical Data Showing Efficacy of Differentiated Approach Targeting Tau in Models of Alzheimer’s Disease and Related Tauopathies

Oligomerix Presents Preclinical Data Showing Efficacy of Differentiated Approach Targeting Tau in Models of Alzheimer’s Disease and Related Tauopathies

Data presented at AAIC demonstrates oral lead product candidate OLX-07010 reduces tau self-association and insoluble tau aggregates Oligomerix to begin clinical testing of OLX-07010 in 2Q22 Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for rare neurodegenerative and Alzheimer’s diseases, announced ...

ByOligomerix, Inc.


Raising Awareness on the Challenges of Hormone Replacement Injections

Raising Awareness on the Challenges of Hormone Replacement Injections

For transitioning individuals taking estrogen, the most common route of administration is orally or through a skin patch. Injectable estrogen tends to cause “very high and fluctuating estrogen levels which can cause mood swings, weight gain, hot flashes, anxiety or migraines, so it is usually not prescribed except in very unique circumstances ...

ByPortal Instruments, Inc.


Blueberry Therapeutics announces extension of its Series B round with investment from Medical Incubator Japan and US Dermatology Syndicate

Blueberry Therapeutics announces extension of its Series B round with investment from Medical Incubator Japan and US Dermatology Syndicate

In onychomycosis, BB2603 aims to achieve equivalent efficacy and treatment duration but at a dose which is several thousand-fold lower than approved for oral terbinafine, thereby avoiding the systemic side effects and patient monitoring requirements of oral administration. ...

ByBlueberry Therapeutics

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT